TOKYO -- Meiji Seika Pharma will partner with the government-affiliated Riken research institute to develop treatments to regrow lost hair, eyeing a full-fledged entry into the booming regenerative medicine field.
Biotechnology
TOKYO -- Meiji Seika Pharma will partner with the government-affiliated Riken research institute to develop treatments to regrow lost hair, eyeing a full-fledged entry into the booming regenerative medicine field.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.